Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product

Broad Microbial Contamination Detection on one platform with results within 8 hours

Product Description

The Abbott PLEX-ID system is the only high-throughput technology that offers rapid, broad identification of known or unknown emerging organisms direct from sample, without the need for culture, enrichment or staining.

The PLEX-ID system provides the ability to screen for thousands of  adventitious agents, such as bacteria, fungi or viruses, in a single analysis with access to results within 8 hours from preparation to identification.  The PLEX-ID is commonly used during the Biopharmaceutical manufacturing process to test for Cell banking, thru to in-process testing and environmental monitoring.

The PLEX-ID technology uses broad PCR coupled with Mass Spectrometer detection to detect and determine the base composition of amplified primer pairs (amplicons) that are used to interrogate conserved regions that flank variable regions of highly conserved genes. The base composition determined for each amplicons is then searched against a database to determine the organisms present. This multilocus approach provides the ability to distinguish between closely related species as well as identify single nucleotide polymorphisms or mutations.

This Technology is not approved for use in diagnostic procedures.

Product Broad Microbial Contamination Detection on one platform with results within 8 hours
Company Abbott Laboratories – Ibis Biosciences Business Unit
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Abbott Laboratories – Ibis Biosciences Business Unit
2251 Faraday avenue, Suite 150 Carlsbad Ca 92008 USA



Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos